Medicine guide

ERELZI

As listed in the register: ERELZI

25 mg · solution

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Etanercept
Made by
Sandoz Canada Incorporated

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL04AB01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (ENBREL). It describes the substance, not this exact product.

TNF is a naturally occurring cytokine that is involved in normal inflammatory and immune responses.

It plays an important role in the inflammatory processes of RA, polyarticular JIA, PsA, and AS and the resulting joint pathology.

Peak level after34 h
Half-life30 h
Mostly cleared after≈ 6 daysfive half-lives — our arithmetic
PeakHalf gone6 days0
The shape is a standard model drawn from the two times above, not a measurement. How fast a medicine acts and wears off also depends on the dose, the form and the person.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-05-11

Safety of the active substance

From the US prescribing label for the same active substance (ENBREL). It describes the substance, not this exact product.

Serious warning

WARNING: SERIOUS INFECTIONS and MALIGNANCIES WARNING: SERIOUS INFECTIONS and MALIGNANCIES See full prescribing information for complete boxed warning.

Must not be used by
  • Enbrel is contraindicated in patients with sepsis.
Most common side effects

The most common adverse reactions with Enbrel were infections and injection site reactions.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made bySandoz Canada Incorporated
Active substanceEtanercept
Used inCancer treatments and immune-system medicines
Strength25 mg
Formsolution
ClassificationL04AB01 · Cancer treatments and immune-system medicines
Routesubcutaneous
Dispensing (as stated by the register)PRESCRIPTION · SCHEDULE D
StatusMarketed
MarketedYes, according to the register
DIN02462877
DPD drug code95074

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.